Evidence map›Paper›PMID 31843876›Full record

ReviewHeart (British Cardiac Society)2020

Lifetime cardiovascular management of patients with previous Kawasaki disease.

Paul Brogan, Jane C Burns, Jacqueline Cornish, Vinod Diwakar, Despina Eleftheriou, John B Gordon, Huon Hamilton Gray, Thomas William Johnson, Michael Levin, Iqbal Malik and 5 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart (British Cardiac Society), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Transition of care for adolescents and young adults with Kawasaki disease: An international survey.International journal of cardiology. Congenital heart disease · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Paul BroganInfection, Inflammation, and Rheumatology, UCL Institute of Child Health, London, UK.
Jane C BurnsPediatrics, University of California, San Diego, California, USA.
Jacqueline CornishNational Clinical Director Children, Young People and Transition to Adulthood, Medical Directorate, NHS England, London, UK.
Vinod DiwakarNHS Improvement, NHS England, London, UK.
Despina EleftheriouInfection, Inflammation, and Rheumatology, UCL Institute of Child Health, London, UK.
John B GordonCardiology, Sharp Memorial Hospital and San Diego Cardiac Center, San Diego, California, USA.
Huon Hamilton GrayNational Clinical Director for Heart Disease, NHS England, London, UK.
Thomas William JohnsonCardiology, Bristol Heart Institute, Bristol, UK.
Michael LevinPaediatrics, Imperial College London, London, UK.
Iqbal MalikImperial College London, International Centre for Circulatory Health, London, UK.
Philip MacCarthyCardiology, Kings College Hospital, London, UK.
Rachael McCormackSocieti, The UK Foundation for Kawasaki Disease, Newark, UK.
Owen MillerDepartment of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Robert M R TullohDepartment of Congenital Heart Disease, Bristol Royal Hospital for Children, Bristol, UK robert.tulloh@bristol.ac.uk.ORCID 0000-0002-3180-6993
Kawasaki Disease Writing Group, on behalf of the Royal College of Paediatrics and Child Health, and the British Cardiovascular Society
NHS EnglandImperial College London · GBUniversity College London · GBBristol Royal Hospital for Children · GBGuy's and St Thomas' NHS Foundation Trust · GBKing's College Hospital · GBNIHR Bristol Cardiovascular Biomedical Research Unit · GBSharp Memorial Hospital · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kawasaki disease (KD) is an inflammatory disorder of young children, associated with vasculitis of the coronary arteries with subsequent aneurysm formation in up to one-third of untreated patients. Those who develop aneurysms are at life-long risk of coronary thrombosis or the development of stenotic lesions, which may lead to myocardial ischaemia, infarction or death. The incidence of KD is increasing worldwide, and in more economically developed countries, KD is now the most common cause of acquired heart disease in children. However, many clinicians in the UK are unaware of the disorder and its long-term cardiac complications, potentially leading to late diagnosis, delayed treatment and poorer outcomes. Increasing numbers of patients who suffered KD in childhood are transitioning to the care of adult services where there is significantly less awareness and experience of the condition than in paediatric services. The aim of this document is to provide guidance on the long-term management of patients who have vascular complications of KD and guidance on the emergency management of acute coronary complications. Guidance on the management of acute KD is published elsewhere.

Indexed as

AdultCardiovascular DiseasesChildDecision TreesHumansMucocutaneous Lymph Node SyndromeTransition to Adult Careacute coronary syndromecardiovascular riskcoronary artery aneurysmKawasaki diseaselate sequelaelifetime cardiovascular managementperson specific protocoltransitional care

Identifiers

PMID31843876
PMCPMC7057818
OpenAlexW2995589138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.